EDRE
NDRM

Edmond de Rothschild (Europe)’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,600
Closed -$23K – 259
2016
Q1 		$23K Hold
1,600
– – 0.01% 196
2015
Q4 		$27K Buy
1,600
+800
+100% +$15.6K 0.01% 200
2015
Q3 		$17K Buy
+800
New +$16.4K 0.01% 218

Other funds holding NDRM

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Edmond de Rothschild (Europe)'s NDRM Position: Q2 2016 in Review

Edmond de Rothschild (Europe) sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2016, closing a stake of 1,600 shares — an estimated $23K sold.

Edmond de Rothschild (Europe) first reported a position in NDRM in Q3 2015 and held it in 3 quarters. The position peaked at $27K in Q4 2015. 50 funds tracked by Wall St. Rank hold NDRM as of Q2 2016.

  • Edmond de Rothschild (Europe) reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • Edmond de Rothschild (Europe) sold 1,600 NeuroDerm Ltd. Ordinary Shares shares in Q2 2016, an estimated $23K.
  • Edmond de Rothschild (Europe) first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 3 quarters.
  • Edmond de Rothschild (Europe)'s NeuroDerm Ltd. Ordinary Shares position peaked at $27K in Q4 2015.
  • 50 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q2 2016, filed 10 Aug 2016.